Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Kidney international. Supplement

• Publication date

  2005-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1523-1755.2005.09501.XPMID 15882315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Parathyroid Hormone mRNA 3′-Untranslated Region AU-rich Element Is an Unstructured Functional Element*

  2004cited by this paper
• Sensing phosphate across the kingdoms

  2003cited by this paper
• Human Calcium-sensing Receptor Gene

  2002cited by this paper
• Regulation of arachidonic acid production by intracellular calcium in parathyroid cells: effect of extracellular phosphate.

  2002cited by this paper
• Mechanisms of secondary hyperparathyroidism.

  2002cited by this paper
• p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium.

  2001cited by this paper
• A Conserved cis-Acting Element in the Parathyroid Hormone 3′-Untranslated Region Is Sufficient for Regulation of RNA Stability by Calcium and Phosphate*

  2001cited by this paper
• p21WAF1 and TGF-α mediate parathyroid growth arrest by vitamin D and high calcium

  2001cited by this paper
• Identification of AUF1 as a Parathyroid Hormone mRNA 3′-Untranslated Region-binding Protein That Determines Parathyroid Hormone mRNA Stability*

  2000cited by this paper
• Mechanism of increased parathyroid hormone mRNA in experimental uremia: roles of protein RNA binding and RNA degradation.

  1999cited by this paper
• RNA-Protein Binding and Post-transcriptional Regulation of Parathyroid Hormone Gene Expression by Calcium and Phosphate*

  1998cited by this paper
• Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice.

  1998cited by this paper
• Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.

  1998cited by this paper
• The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor.

  1997cited by this paper
• A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells.

  1996cited by this paper
• Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro

  1996cited by this paper
• The reduced responsiveness of cultured bovine parathyroid cells to extracellular Ca2+ is associated with marked reduction in the expression of extracellular Ca(2+)-sensing receptor messenger ribonucleic acid and protein.

  1995cited by this paper
• Parathyroid hormone gene expression in hypophosphatemic rats.

  1995cited by this paper
• Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

  1995cited by this paper
• Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression.

  1995cited by this paper
• Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid

  1993cited by this paper
• Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.

  1990cited by this paper
• Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat.

  1990cited by this paper
• Recent Advances in the Structure and Function of the Parathyroid Gland in Animals and the Effects of Xenobiotics

  1989cited by this paper
• Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat.

  1989cited by this paper
• Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas.

  1988cited by this paper
• Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

  1986cited by this paper
• Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells.

  1985cited by this paper
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

  1984cited by this paper
• Vitamin D and Hyperparathyroidism

  1981cited by this paper
• Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.

  1981cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Endothelin Receptor Antagonist Prevents Parathyroid Cell Proliferation of Low Calcium Diet-Induced Hyperparathyroidism in Rats

  year unknowncited by this paper

• Hyperparathyroidism and Peripheral Arterial Disease.

  2024cites this paper
• New Emerging Aspect of Herbal Extracts for the Treatment of Osteoporosis: Overview.

  2024cites this paper
• Prevalence and severity of sarcopenia in patients on maintenance hemodialysis: a cross-sectional study

  2024cites this paper
• Secondary hyperparathyroidism in chronic kidney disease: A narrative review focus on therapeutic strategy

  2024cites this paper
• Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis

  2024cites this paper
• Vitamin D deficiency and secondary hyperparathyroidism in adult Fontan patients

  2024cites this paper
• Association of Secondary Hyperparathyroidism with Cardiac Structural and Functional Abnormality in Chronic Kidney Disease Stage 4, 5 and Hemodialysis Patients

  2024cites this paper
• Use machine learning to help identify possible sarcopenia cases in maintenance hemodialysis patients

  2023cites this paper
• ACTUALITIES IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM DUE TO CHRONIC KIDNEY DISEASE IN CHILDREN.

  2023cites this paper
• Osteocalcin modulates parathyroid cell function in human parathyroid tumors

  2023cites this paper
• The Induction of Parathyroid Cell Differentiation from Human Induced Pluripotent Stem Cells Promoted Via TGF-α/EGFR Signaling

  2023cites this paper
• Complications et prise en charge thérapeutique des anomalies du métabolisme phosphocalcique de l’insuffisance rénale chronique

  2023cites this paper
• Some genetic differences in patients with rheumatoid arthritis

  2023cites this paper
• VITAMIN D DEFICIENCY IMPACT ON BONE MINERAL DENSITY, SERUM CALCIUM/PHOSPHATE AND PARATHYROID HORMONE LEVELS IN TYPE 2 DIABETIC FEMALES VERSUS NON-DIABETICS

  2023cites this paper
• Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters

  2022influential citation
• Molecular Mechanisms of Parathyroid Disorders in Chronic Kidney Disease

  2022cites this paper
• Systematic Review of the Treatment of Persistent Hyperparathyroidism Following Kidney Transplantation

  2022cites this paper
• The Role of Gum Arabic for a Protective Kidney Dysfunction Induced Gentamicin on Diabetes Rats

  2022cites this paper
• Skeletal and extraskeletal disorders of biomineralization

  2022cites this paper
• Calcium and phosphate homeostasis in dogs with newly diagnosed naturally occurring hypercortisolism

  2021cites this paper
• Environmental Factors That Affect Parathyroid Hormone and Calcitonin Levels

  2021cites this paper
• Dietary calcium to phosphorus ratio affects postprandial phosphorus concentrations in feline plasma

  2021cites this paper
• Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management

  2021cites this paper
• Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease

  2020cites this paper
• [Complications and treatment of mineral and bone disorders in chronic kidney disease].

  2019cites this paper
• Fulminant Skeletal Failure in a Centenarian: The Impact of Nutrition and Immobility

  2019cites this paper
• SON DÖNEM KRONİK BÖBREK YETMEZLİĞİNDE PARATİROİD BEZLERİNİN ULTRASONOGROFİK BOYUTLARININ KALSİYUM METABOLİZMASI VE KEMİK DÖNGÜSÜ İLE İLİŞKİSİ VE ERİTROPOETİN TEDAVİSİNİN ROLÜ

  2019cites this paper
• Study of Metacarpocortical Index ( MCI ) In Chronic Kidney Disease Dr .

  2018cites this paper
• The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency

  2018cites this paper
• Association of Serum Parathyroid Hormone and Vitamin D Levels with Cardiovascular Risk Factors

  2017cites this paper
• Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients

  2017cites this paper
• Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.

  2017cites this paper
• The differences in acid-base status and the calcium parathyroid axis between peritoneal dialysis and hemodialysis.

  2016cites this paper
• Serum Parathyroid Hormone Concentrations and Clinical Outcomes in ESRD: A Call for Targeted Clinical Trials

  2016cites this paper
• Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients

  2016cites this paper
• Prevalence of Hyperparathyroidism, Mineral and Bone Disorders in Children with Advanced Chronic Kidney Disease

  2016cites this paper
• Molecular patterns of diffuse and nodular parathyroid hyperplasia in long-term hemodialysis.

  2016cites this paper
• The association of abdominal obesity, obesity and parathyroid hormone in Korean adults (aged≥50 years): The Korea National Health and Nutrition Survey, 2011

  2015cites this paper
• Application of total parathyroidectomy with auto-transplantation for uremia secondary hyperparathyroidism treatment.

  2015cites this paper
• Complications et prises en charge thérapeutiques des anomalies du métabolisme phosphocalcique de l’insuffisance rénale chronique

  2014cites this paper
• Can parathyroid hormone be used as a biomarker for heart failure?

  2013cites this paper
• Management of Calcium and Bone Disease in Renal Patients

  2013cites this paper
• The role of FGF23/Klotho in mineral metabolism and chronic kidney disease

  2013cites this paper
• Serum Fetuin-A in Egyptian Pediatrics with Chronic End-stage Renal Diseases: A Correlation to Vascular Inflammatory Biomarkers

  2013cites this paper
• Cinacalcet for secondary hyperparathyroidism: from improved mineral levels to improved mortality?

  2013cites this paper
• Study Of Cardic Valvular Calcification In ESRD Patients On Regular Hemodialysis (A Single Center Study)

  2012cites this paper
• Vitamin D, Calcimimetic Agents, and Phosphate Binders

  2012cites this paper
• Phosphate Homeostasis Regulatory Mechanisms

  2012cites this paper
• Chronic Kidney Disease and Mineral and Bone Disorder Management

  2012cites this paper
• Study of Cardiac Valvular Calcification in ESRD Patients on Regular Hemodialysis (A Single Center Study)

  2012cites this paper
• Fibroblast Growth Factor 23 in Children With End Stage Renal Disease on Hemodialysis

  2012cites this paper
• Phosphate sensing.

  2011cites this paper
• Chronic kidney disease--mineral and bone disorder: a complex scenario.

  2011cites this paper
• Effect of high-flux versus low-flux dialysis membranes on parathyroid hormone.

  2010cites this paper
• Parathyroid gland regulation: contribution of the in vivo and in vitro models

  2010cites this paper
• Minerálová a kostní nemoc při chronickém onemocnění ledvin - histomorfometrická kostní analýza

  2010cites this paper
• Influence of chronic renal failure on acid secretion in isolated gastric mucosal cells from human biopsies.

  2010cites this paper
• Modulation du cytochrome P450 par l’insuffisance rénale chronique dans un modèle murin transgénique

  2010cites this paper
• 25-Hydroxyvitamin D Status Does Not Affect Intraoperative Parathyroid Hormone Dynamics in Patients with Primary Hyperparathyroidism

  2010cites this paper
• Page 1 of 32 PARATHYROID GLAND REGULATION: CONTRIBUTION OF THE IN VIVO AND IN VITRO MODELS Authors and affiliations:

  2010cites this paper
• Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?

  2009cites this paper
• Molecular Biology of Parathyroid Hormone

  2009cites this paper
• Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.

  2009cites this paper
• Modulation du cytochrome P450 dans un modèle murin d'insuffisance rénale chronique

  2009cites this paper
• Analysis of CYP27B1, Encoding 25‐Hydroxyvitamin D‐1α‐Hydroxylase, as a Candidate Tumor Suppressor Gene in Primary and Severe Secondary/Tertiary Hyperparathyroidism

  2009cites this paper
• Sexual function in women undergoing hemodialytic treatment assessed using the female sexual function index (FSFI) and the somatic inkblot series (SIS) test.

  2008cites this paper
• Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs

  2008influential citation
• CHAPTER 94 – Management of Calcium and Bone Disease in Renal Patients

  2008cites this paper
• Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol.

  2008cites this paper
• Modality of Dialysis and the Management of Secondary Hyperparathyroidism

  2008cites this paper
• Phosphathaushalt bei chronischer Niereninsuffizienz

  2007cites this paper
• Failure of successful renal transplant to produce appropriate levels of 1,25-dihydroxyvitamin D

  2007cites this paper
• Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial

  2007cites this paper
• Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.

  2007cites this paper
• Quality of life and sexuality in chronic dialysis female patients

  2006cites this paper
• Serum concentrations of calcium, phosphorus, magnesium and calciotropic hormones in donkeys.

  2006cites this paper
• Can hyperparathyroid bone disease be arrested or reversed?

  2006cites this paper
• Transition of Patients from Chronic Kidney Disease to End-Stage Renal Disease: Better Practices for Better Outcomes

  2006cites this paper
• Calcimiméticos en el hiperparatiroidismo secundario

  2005cites this paper
• Relationship between parathyroid hormone level and parathyroid Relationship between parathyroid hormone level and parathyroid gland size and numbers in renal hyperparathyroidism gland size and numbers in renal hyperparathyroidism

  year unknowncites this paper
• Predictors of Surgical Success in Parathyroidectomy: A Retrospective Study of Patients Receiving Renal Replacement Therapy with Secondary Hyperparathyroidism

  year unknowncites this paper